AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Simulations Plus Inc. (SLP)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

31.92

-3.98 (-11.09%)

At close: Feb 20, 2025, 3:59 PM

31.39

-1.66%

After-hours: Feb 20, 2025, 05:43 PM EST

undefined% (undefined)

Bid	30.87
Market Cap	641.35M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	0.4
PE Ratio (ttm)	79.8
Forward PE	n/a
Analyst	Buy

Ask	32.88
Volume	234,587
Avg. Volume (20D)	237,042
Open	35.62
Previous Close	35.90
Day's Range	31.92 - 35.70
52-Week Range	24.00 - 51.22
Beta	undefined

About SLP

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus...

[Show more]

Industry Medical - Healthcare Information Services

Sector Healthcare

IPO Date Jun 18, 1997

Employees 243

Stock Exchange NASDAQ

Ticker Symbol SLP

Website https://www.simulations-plus.com

Full Company Profile

Analyst Forecast

According to 7 analyst ratings, the average rating for SLP stock is "Buy." The 12-month stock price forecast is $50, which is an increase of 56.64% from the latest price.

Buy 85.71%

Hold 14.29%

Sell 0.00%

Stock Forecasts

Why Price Moved

1 month ago

-7.17%

Simulations Plus shares are trading lower after Ke... Unlock content with Pro Subscription

4 months ago

-8.89%

Simulations Plus shares are trading lower after the company reported worse-than-expected Q4 revenue results.

News

2 weeks ago · businesswire.com

Simulations Plus to Participate in Upcoming Healthcare Investor Conferences

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”, “SLP”), a leading provider of cheminformatics, biosimulation, simulation-enabled performance an...

1 month ago · businesswire.com

Simulations Plus and Enabling Technologies Consortium Announce Strategic Collaboration to Advance GastroPlus® Enhancements

RESEARCH TRIANGLE, N.C.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of biosimulation, simulation-enabled performance and intelligence solutions, and...

1 month ago · businesswire.com

Simulations Plus Supported Development of Majority of FDA-Approved Drugs in 2024

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--SLP highlighted its impact on the pharma industry through support of the development of a majority of the drugs approved by the U.S. FDA in 2024.

1 month ago · businesswire.com

Simulations Plus Supported Development of Every FDA-Approved Drug in 2024

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--SLP highlighted its impact on the pharmaceutical industry through supporting the development of 100% of the drugs approved by the U.S. FDA in 2024.

1 month ago · zacks.com

Simulations Plus' Q1 Earnings Lag Estimates, Revenues Surge Y/Y

SLP's fiscal first-quarter performance is driven by healthy revenue growth across its Software segment and contributions from the acquisition of Pro-ficiency.

1 month ago · seekingalpha.com

Simulations Plus, Inc. (SLP) Q1 2025 Earnings Call Transcript

Simulations Plus, Inc. (NASDAQ:SLP ) Q1 2025 Earnings Conference Call January 7, 2025 5:00 PM ET Company Participants Lisa Fortuna - IR, Financial Profiles Shawn O'Connor - CEO Will Frederick - CFO & ...

1 month ago · zacks.com

Simulations Plus (SLP) Lags Q1 Earnings Estimates

Simulations Plus (SLP) came out with quarterly earnings of $0.17 per share, missing the Zacks Consensus Estimate of $0.18 per share. This compares to earnings of $0.10 per share a year ago.

1 month ago · businesswire.com

Simulations Plus Reports First Quarter Fiscal 2025 Financial Results

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intel...

1 month ago · zacks.com

3 Software Stocks to Keep an Eye on Amid Industry Headwinds

Amid volatile macroeconomic conditions, Computer Software industry participants like ADSK, BB and SLP are well-poised to capitalize on digital transformation and strong adoption of cloud computing sol...

1 month ago · zacks.com

Simulations Plus Gears Up for Q1 Earnings: What's in Store?

SLP's fiscal first quarter performance is likely to have gained from strength in both Software and Services' segments.

Load More News